198 related articles for article (PubMed ID: 16716167)
1. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
2. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
5. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
6. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
7. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
8. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
9. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774
[TBL] [Abstract][Full Text] [Related]
10. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur.
Onuoha GN; Alpar EK
Neuropeptides; 2000 Apr; 34(2):116-20. PubMed ID: 10985928
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
Reich A; Orda A; Wiśnicka B; Szepietowski JC
Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
[TBL] [Abstract][Full Text] [Related]
12. Serum oxidant/antioxidant status in patients with Behçet's disease.
Taysi S; Kocer I; Memisogullari R; Kiziltunc A
Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
[TBL] [Abstract][Full Text] [Related]
13. Cytokines in Behçet's disease.
Sayinalp N; Ozcebe OI; Ozdemir O; Haznedaroğlu IC; Dündar S; Kirazli S
J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
[TBL] [Abstract][Full Text] [Related]
14. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
15. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction.
Kawakami T; Ohashi S; Kawa Y; Takahama H; Ito M; Soma Y; Mizoguchi M
Arch Dermatol; 2004 May; 140(5):570-4. PubMed ID: 15148101
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
18. Classifying patients with Behçet's disease for disease severity, using a discriminating analysis method.
Polat M; Vahaboglu G; Onde U; Eksioglu M
Clin Exp Dermatol; 2009 Mar; 34(2):151-5. PubMed ID: 19187295
[TBL] [Abstract][Full Text] [Related]
19. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity.
Inanc N; Mumcu G; Birtas E; Elbir Y; Yavuz S; Ergun T; Fresko I; Direskeneli H
J Rheumatol; 2005 Feb; 32(2):287-91. PubMed ID: 15693089
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
